A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine With Digoxin for Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
- Status
- COMPLETED
- Phase
- PHASE1
BP-C1 in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Breast Cancer Molecular Analysis Protocol
- Status
- COMPLETED
- Phase
- N/A
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
- Status
- TERMINATED
- Phase
- NA
cMet CAR RNA T Cells Targeting Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Value of 89Zr-trastuzumab PET
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone and SBRT For Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel
- Status
- UNKNOWN
- Phase
- N/A
Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
- Status
- COMPLETED
- Phase
- PHASE2
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2